4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands,申请号US20080030439-传众专利搜索

4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands

申请公布号：US7662817(B2)

申请号：US20080030439

申请日期：2008.02.13

申请公布日期：2010.02.16

发明人：GILLIGAN PAUL J.

分类号：C07D487/04;A61K31/53;A61P25/22;A61P25/24;C07D401/04

主分类号：C07D487/04

摘要：Corticotropin releasing factor (CRF) antagonists of Formula (I): and its use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.